Stem cell transplantation therapy for acute myeloid leukemia

Abstract

Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy, presenting a significant challenge in the field of medicine. In this context, Hematopoietic Stem Cell Transplantation (HSCT) has garnered widespread attention as a potential therapeutic approach. This paper reviews the current research progress in the field of AML treatment, with a specific focus on the application of HSCT. Through a comprehensive analysis of recent literature and clinical trials, it systematically summarizes the therapeutic effects of HSCT in different patient populations. Despite demonstrating certain efficacy in AML treatment, there remain research gaps in the application of HSCT, particularly in specific patient groups and contexts. This paper extensively discusses the principles, types, and application scenarios of HSCT in AML patients. By reviewing recent research findings, this article analyzes the treatment outcomes of HSCT in both young and elderly patients and compares relevant survival data. This paper presents future prospects for research, including in-depth investigations into novel HSCT treatment strategies, the impact of age differences on treatment outcomes, and more. These prospects aim to provide more precise directions for improving the therapies for AML patients.